Basics Inhibrx, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.3B Activated in VL: True Average Daily Range Avg Daily Range: $0.84 | 3.46% Avg Daily Range (30 D): $3.32 | 5.03% Avg Daily Range (90 D): $1.69 | 3.64% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .52M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 43 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 1,295 Avg Inst. Trade: $2.17M Avg Inst. Trade (30 D): $1.39M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.13M Avg Closing Trade (30 D): $1.57M Avg Closing Trade (90 D): $1.52M Avg Closing Volume: 79.22K     News Oct 24, 2025 @ 5:22 PM Stocks Soar To Records After Weak Inflation, Ford ... Source: Piero Cingari Oct 24, 2025 @ 7:05 AM Why Are Inhibrx Biosciences Shares Soaring 76% Aft... Source: Mohd Haider Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-11.96 $-2.28 Diluted EPS $-11.4 $-2.28 Revenue $ 1.4M $ M $ Gross Profit $ $ $ Net Income / Loss $ -155.09M $ -35.26M $ -28.65M Operating Income / Loss $ -154.03M $ -33.81M $ Cost of Revenue $ $ $ Net Cash Flow $ -43.24M $ $ PE Ratio